Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 0 | 0% | $ 8.1M |
3/31/2025 | $ 0 | 0% | $ 7.22M |
12/31/2024 | $ 0 | 0% | $ 8.33M |
9/30/2024 | $ 0 | 0% | $ 9.91M |
6/30/2024 | $ 0 | 0% | $ 12.87M |
3/31/2024 | $ 0 | 0% | $ 14.16M |
12/31/2023 | $ 0 | 0% | $ 15.45M |
9/30/2023 | $ 0 | 0% | $ 14.35M |
6/30/2023 | $ 0 | 0% | $ 9.6M |
3/31/2023 | $ 0 | 0% | $ 7.21M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for TAYSHA GENE THERAPIES INC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 0 ]
(=) COGS % [ 0% ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.81K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.91% |
median | 50.54% |
std | 31.59% |